Share
Prothrombin Complex Concentrate Market Size, Share, and Analysis, By Product (3-Factor PCC, 4-Factor PCC), By Application (Congenital Coagulation Factor Deficiency, Acquired Coagulation Factor Deficiency), By End-Use (Hospitals, Ambulatory Surgical Centres, Specialty Clinics and Others) and Regional Forecasts, 2022-2032
Prothrombin Complex Concentrate size was USD 727.5 million in 2021 and projected to grow from USD 883.9 million in 2023 to USD 2153.2 million by 2032, exhibiting a CAGR of 10.4% during the forecast period.
Prothrombin Complex Concentrate (PCC) is also known as factor lX complex, which is a medicament created using blood clotting factors ll, lX, and X which helps in the treatment of bleeding disorders. Few versions of PCC even contain factor Vll. PCC is obtained from human plasma and contains concentrated coagulation factors. It is utilized to resolve and prevent bleeding in haemophilia B and is used in insufficiency of these components due to warfarin treatment etc. It is incorporated into the body using a syringe into vein. By administering through IV, PCC refillls the coagulation factors in the blood immediately.
Prothrombin Complex Concentrate Market is expected to reach USD 2153.2 million, growing at a CAGR of 10.4% during forecast period. Prothrombin Complex Concentrate (PCC) is anticipated to increase due to the presence of several clinical advantages over fresh frozen plasma (FPP). PCC take less volume and time to infuse compared with FPP and is efficient. PCC has no requirement for blood matching and thawing which increases the preference and demand for PCC market growth. The relaxation of government regulations and policies have created positive impact for the growth of the PCC market.
Prothrombin Complex Concentrate Market is classified based on the Product into 3-Factor PCC, 4-Factor PCC. The 4-factor segment dominated the market in 2021 owing to the enhanced penetration of 4-factor PCC in developing countries and their efficacy for warfarin reversal which helped to boost the growth of the market. The government initiatives to reduce adverse events related to warfarin is anticipated to boost the growth of segment. The 3-factor segment is expected to dominate the market in the forecast period owing to the increasing prevalence of haemophilia and growing demand for plasma products which is expected to drive the segment growth.
Prothrombin Complex Concentrate Market is classified based on the End-Use into Hospitals, Ambulatory Surgical Centres, Specialty Clinics and Others. The hospitals segment dominated the market in 2021 owing to the increasing preference for prothrombin complex concentrate, favourable government initiatives, and increased obtaining of plasma products. Specialty clinics segment is anticipated to grow in forecast period due to the growing surgeons and increasing number of privately-owned clinics.
Growing Haemophilia B Issues is Expected to Boost the Growth of the Market
The growing prevalence of Haemophilia B is expected to boost the growth of the market. The initiation of different kinds of Vitamin K antagonist products is expected to increase the usage of Prothrombin Complex Concentrate. The use of warfarin has increased which is expected to boost the market growth. The positive government regulations and norms for the use of factor IX complex for warfarin reversal is expected to boost the market growth. The increased incidence of bleeding disorders has also created growth option for the Prothrombin Complex Concentrate market.
Advantages of Prothrombin Complex Concentrate May Boost the Market Growth
PCC possess several advantages over many other alternatives like Vitamin K1, FFP etc., which is responsible for usage in urgent warfarin-reversals. PCC has minimal risk of viral transmission. PCC removes the necessity of blood matching & thawing, unlike FFP and it provide less penetration time with high efficiency and require less volume which may boost the growth of the Prothrombin Complex Concentrate market. Increasing surgeries requiring the need of PCC may also boost the market as the surgical procedures have necessity to manage coagulation disorders.
High Procurement Cost May Restrain the Growth of the Market
The high rate of competition and growing procurement costs may restrain the growth of PCC market in the forecast period. The thrombotic complications which might arise from the use of PCC may also restrain the growth of the market.
Prothrombin Complex Concentrate Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America dominated the market in 2021 owing to the presence of key market players, increasing demand for PCC which created demand for growth of the market in the region. Asia Pacific region is expected to dominate the market in the forecast period owing to the increasing use of number of patients and government initiatives to improve the therapies which is expected to boost the growth of the Prothrombin Complex Concentrate Market.
The COVID-19 outbreak had resulted in the downfall of economies worldwide. Several countries had imposed lockdowns and applied travel restrictions to control the spread of the virus. Due to the restrictions imposed, there was improper connectivity which led to disruptions in the supply of PCC and blood-derivatives but pandemic created requirement for PCC. Covid-19 pandemic, in total had slight positive impact for the growth of the market.
Prothrombin Complex Concentrate Market Scope and Segments:
|
ATTRIBUTE |
DETAILS |
|
Study Period |
2018-2032 |
|
Base Year |
2022 |
|
Forecast Period |
2021-2032 |
|
Historical Period |
2019-2021 |
|
Growth Rate |
CAGR of 10.4% from 2022-2032 |
|
Unit |
Value (USD Million) |
|
Segmentation |
Main Segments List |
|
Product |
|
|
Application |
|
|
End-Use |
|
|
By Region |
|
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
